iterumtx.com (ITRM) Cash Funds Calculated per Share

Corporate emblem and logo of Iterum Therapeutics PLC (ITRM)

The cash per share metric demonstrates liquidity dynamics, where the value of 0.00 expresses the level of the metric. Iterum Therapeutics plc (ITRM) is valued by physicians for its development of antibiotics against resistant infections. The scientific team operates under conditions of academic freedom, receiving bonuses for testing milestones. The company is currently transitioning to active sales of its oral drug in the US market following FDA approval.

Iterum Therapeutics PLC (ITRM) Cash per Single Share: for the period 07/04/2022 - 04/11/2026

Analytical breakdowns for Iterum Therapeutics plc

- current price and projected stock value:
- cash position and cash flow details:
General company analysis:ITRM, Iterum Therapeutics PLC
Original product of Iterum Therapeutics plc

Iterum Therapeutics plc relies on outsourcing antibiotic production, making liquidity control critically important. This cash per share metric is calculated by dividing the total amount of cash by the number of outstanding shares. The metric digitizes the actual reserve of "liquid" cash available for each ownership stake. This chart reflects the company's ability to fund external partners without equity dilution. For the investor, this serves as an indicator of financial stability or developmental stagnation.